Regulation of peptidyl-lysine acetylation

pathway activity — cross-omics
GO:2000756Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Regulation of peptidyl-lysine acetylation pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SYNPO2, PDLIM3, and PTH1R, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Regulation of peptidyl-lysine acetylation activity versus SYNPO2 in GBM (Pearson r = -0.18).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMSYNPO2 →-0.724-0.272<.001<.00137
UCECPDLIM3 →-1.334-0.168.003.00236
BRCAPTH1R →-0.559-0.194<.001<.00136
OVLMOD1 →-1.393-0.238<.001<.00136
OVZCCHC24 →-1.287-0.189<.001.00336
GBMPTPRH →-0.722-0.182<.001.00236
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:2000756 vs SYNPO2 — GBM

Per-sample scatter of Regulation of peptidyl-lysine acetylation activity vs SYNPO2 in GBM.

Explore this scatter interactively →

Exploration